India plans to introduce HPV testing in cancer control
Hindustan Times — April 17, 2024, 04:00 PM UTC
Summary: The Union health ministry plans to introduce HPV testing in India's National Cancer Control Programme due to the high risk of cervical cancer. India has 511.4 million women at risk, with 1,23,907 new cases and 77,348 deaths annually. HPV vaccines have significantly reduced infections and precancers in the US. The Serum Institute of India launched Cervavac, priced at ₹2,200, to encourage vaccination.
Article metrics
Significance6.0
Scale8.0
Magnitude7.5
Potential8.5
Novelty6.0
Actionability7.0
Immediacy8.0
Positivity9.0
Credibility8.0